EZH2 and ovarian cancer: This putative proangiogenic role for EZH2 in ovarian cancer is supported by in vitro studies where EZH2 knockdown reduced human umbilical vein endothelial cell (HUVEC) migration and endothelial tube formation in Matrigel [93].